Position in RXRX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$44,040
-$9,130 QoQ
Shares Held
12,000
-7.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#247
of 340 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LVW Advisors, LLC holds $2,070,056 across 8 Biotechnology names. RXRX ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
898 | $446,063 | |
| 2 | CYTK |
Cytokinetics Inc
|
4,234 | $360,694 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
4,333 | $322,721 | |
| 4 | ASND |
Ascendis Pharma A/S
|
946 | $252,317 | |
| 5 | ARGX |
Argenx SE
|
240 | $222,664 | |
| 6 | NKTR |
Nektar Therapeutics
|
3,022 | $210,965 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
739 | $210,592 | |
| 8 | RXRX |
Recursion Pharmaceuticals, Inc.
This page
|
12,000 | $44,040 |
All Filings in RXRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,040 | 12,000 | Shares | Sole | 2026-07-15 | |
| 2025-12-31 | $53,170 | 13,000 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $63,440 | 13,000 | Shares | Sole | 2025-10-20 | |
| No filing history on record for this holder in this stock. | ||||||